行情

PETQ

PETQ

PetIQ
NASDAQ

实时行情|Nasdaq Last Sale

30.30
+0.02
+0.07%
盘后: 30.30 0 0.00% 16:08 01/28 EST
开盘
30.54
昨收
30.28
最高
30.92
最低
30.01
成交量
14.19万
成交额
--
52周最高
36.33
52周最低
21.28
市值
8.57亿
市盈率(TTM)
-171.0898
分时
5日
1月
3月
1年
5年

分析师评级

6位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

PETQ 新闻

  • 苹果假期季度业绩强于预估 受iPhone需求强劲提振
  • 新浪财经.2小时前
  • 南非亿万富翁说非洲人爱特朗普 被痛批后道歉
  • 新浪财经.3小时前
  • 日产在美销量大减 将向当地老员工提供工龄买断计划
  • 新浪财经.4小时前
  • 澳大利亚科学家成功培育出新型冠状病毒样本
  • 中国新闻网.4小时前

更多

所属板块

制药
+0.48%
制药与医学研究
+0.58%

热门股票

名称
价格
涨跌幅

PETQ 简况

PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
展开

Webull提供PetIQ Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。